Evidence map›Paper›PMID 41624204›Full record

ArticleFrontiers in nutrition2025

Effects of lifestyle intervention and supplementation with insoluble oat fiber on cognitive functions in patients with prediabetes: a secondary analysis of the Optimal Fiber Trial.

Stefan Kabisch, Federico Montagna, Caroline Honsek, Margrit Kemper, Christiana Gerbracht, Ayman M Arafat, Andreas L Birkenfeld, Ulrike Dambeck, Martin A Osterhoff, Martin O Weickert and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01681173 (Investigation of the Effect of Insoluble Dietary Fiber on Carbohydrate and Lipid Metabolism and the Prevention of Diabetes Mellitus Type 2 in Subjects With Impaired Glucose Tolerance), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01681173 nacompletednot on this map

Investigation of the Effect of Insoluble Dietary Fiber on Carbohydrate and Lipid Metabolism and the Prevention of Diabetes Mellitus Type 2 in Subjects With Impaired Glucose Tolerance

TypeinterventionalSponsorGerman Institute of Human NutritionRan2010 to 2014Enrolled200ConditionsDiabetes, Nutrition Disorders, Obesity, OverweightArmsFiber, Placebo
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stefan KabischDepartment of Endocrinology and Metabolic Medicine, Campus Benjamin Franklin, Charité University Medicine, Berlin, Germany.
Federico MontagnaDepartment of Endocrinology and Metabolic Medicine, Campus Benjamin Franklin, Charité University Medicine, Berlin, Germany.
Caroline HonsekDepartment of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Margrit KemperDeutsches Zentrum für Diabetesforschung e.V., Geschäftsstelle am Helmholtz-Zentrum München, Neuherberg, Germany.
Christiana GerbrachtDepartment of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Ayman M ArafatDepartment of Endocrinology and Metabolic Medicine, Campus Benjamin Franklin, Charité University Medicine, Berlin, Germany.
Andreas L BirkenfeldDeutsches Zentrum für Diabetesforschung e.V., Geschäftsstelle am Helmholtz-Zentrum München, Neuherberg, Germany.
Ulrike DambeckDepartment of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Martin A OsterhoffDepartment of Endocrinology and Metabolic Medicine, Campus Benjamin Franklin, Charité University Medicine, Berlin, Germany.
Martin O WeickertWarwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, Coventry, United Kingdom.
Agnes FlöelDepartment of Neurology, University Medicine Greifswald, Greifswald, Germany.
Andreas F H PfeifferDepartment of Endocrinology and Metabolic Medicine, Campus Benjamin Franklin, Charité University Medicine, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In cohort studies, intake of insoluble cereal fiber is associated with multiple health benefits, including preserved cognitive functions. However, evidence from intervention studies is sparse. In the Optimal Fiber Trial (OptiFiT), lifestyle changes and supplementation with oat fiber in prediabetes patients improved glycemic metabolism and body composition, which could be linked to cognitive changes. Methods: In OptiFiT, 180 patients with impaired glucose tolerance received either an insoluble fiber supplement or a placebo for 2 years in a double-blind, randomized approach, and underwent a parallel 1-year complex lifestyle intervention program. Annual visits included metabolic, anthropometric, and cognitive assessments: Mini-Mental State Examination (MMSE), Verbal Learning Memory Test (VLMT), Regensburg Word Fluency Test (RWFT), Number Connection Test (NCT), Number Recall Test (NRT), and Rey-Osterrieth Complex Figure Test (RCFT). Group-wise comparisons were conducted both globally as well as stratified by age. Results: Cognitive functions only slightly improved-particularly in VLMT and RWFT-without major differences by group or age. At baseline, cognitive function measured by RCFT recall, VLMT, RWFT, and backwards NRT was inversely correlated with age, but not with HbA1c, fasting, or postprandial glucose levels. Conclusion: Beneficial effects of insoluble fiber and lifestyle intervention on glycemia might not translate into preserved cognitive capabilities in middle-to-higher aged patients with prediabetes in a 2-year intervention period. Long-term intervention studies in patients with both cognitive vulnerability and metabolic susceptibility are warranted. Such large RCTs should also corroborate putatively involved mechanisms in the epidemiologically assumed protection from cognitive decline. Clinical trial registration: Clinicaltrials.gov, identifier NCT01681173.

Indexed as

cognitiondiabetes preventionimpaired glucose toleranceinsoluble fiberlearningmemoryprediabetestype 2 diabetes

Identifiers

PMID41624204
PMCPMC12857309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.